Highlighting how technology and mindset shifts can help expand breast cancer research leadership beyond high-income countries ...

Discover the future of schizophrenia research. Join CenExel experts Dr. David Walling and Dr. Lara Shirikjian as they explore ...

Examining how shifting leadership patterns in breast cancer research signal growing international participation—and the ...

Medidata will be expanding its long-standing partnership with Sanofi, now leveraging Medidata Patient, Data, and Study Experiences within the collaboration. The ecosystem of tools aims to address ...

Revisit top insights from SCOPE Summit 2025, where industry leaders explored how artificial intelligence is reshaping trial ...

At ESMO 2025, AstraZeneca reported that Imfinzi plus BCG therapy reduced the risk of recurrence or death by 32% in patients ...

Today’s ACT Brief explores how eConsent is modernizing participant engagement, highlights new data on global representation in breast cancer trials, and examines Moderna’s decision to halt its Phase ...

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical ...

Unlock the advantage of pragmatic trials and improve efficiency and real-world relevance to reduce risk and strengthen ...

Edwards also noted the shift towards adaptive trial designs and the benefits of staying with the same CRO for continuity.

In contrast, a DL model can offer precise, AI-generated coding suggestions for adverse events and concomitant medications at up to 99% accuracy. The model can adapt to different scenarios, removing ...

Gain insight into why early toxicology readiness and strong scientific collaboration with CRO partners are critical to ...